FDA Inspection 592267 — Spear Dermatology Products Inc.
The FDA completed an inspection of Spear Dermatology Products Inc. on Jun 18, 2009 in Randolph, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 18, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Randolph, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)
Citations
| ID | CFR | Description |
|---|---|---|
| 4389 | 21 CFR 211.198(a) | Procedures to be written and followed |
| 6842 | 21 CFR 314.80(j) | Failure to maintain records |